SCHEMBL4154037

SCHEMBL4154037

CNc1ccc(SSc2ccc(NC)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
MAPT P10636 2/20 0.54
TSHR P16473 1/20 0.48
APP P05067 5/20 0.42
HSD17B10 Q99714 3/20 0.41
RECQL P46063 2/20 0.41
HPGD P15428 2/20 0.41
CA12 O43570 2/20 0.41
CA2 P00918 2/20 0.41
CA1 P00915 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
THRB P10828 1/20 0.41
ALOX15 P16050 1/20 0.41
CASP1 P29466 1/20 0.41
HIF1A Q16665 1/20 0.41
ADRA2A P08913 2/20 0.39
ADRA2B P18089 2/20 0.39
ADRA2C P18825 2/20 0.39
KIF11 P52732 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20885150 0.88 ALDH1A1 (0.45) ALDH1A1MAPTTSHRAPPHSD17B10
SCHEMBL11507985 0.82 ALDH1A1 (0.54) ALDH1A1MAPTTSHRAPPHSD17B10
SCHEMBL153943 0.80 TSHR (0.67) ALDH1A1MAPTTSHRAPPHSD17B10
SCHEMBL6971804 0.80 ALDH1A1 (0.52) ALDH1A1MAPTTSHRAPPRECQL
SCHEMBL24140273 0.78 ALDH1A1 (0.50) ALDH1A1MAPTTSHRAPPHSD17B10
SCHEMBL20038680 0.78 ALDH1A1 (0.50) ALDH1A1MAPTTSHRAPPHSD17B10
SCHEMBL4636150 0.78 ALDH1A1 (0.50) ALDH1A1MAPTTSHRAPPHSD17B10
Bromide SCHEMBL7630752 0.77 TSHR (0.62) ALDH1A1MAPTTSHRAPPHSD17B10
Hydrochloric Acid SCHEMBL2801770 0.77 TSHR (0.62) ALDH1A1MAPTTSHRAPPHSD17B10
Hydrochloric Acid SCHEMBL6241253 0.77 TSHR (0.62) ALDH1A1MAPTTSHRAPPHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 ALDH1A1 1454/4885MAPT 4585/4885TSHR 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.